NRIX
NASDAQStockNurix Therapeutics, Inc.
$15.03-0.58 (-3.72%)
52-Week Range
$8.24
$21.47
Key Stats
Market Cap
1.3B
P/E Ratio
—
Dividend Yield
—
Beta
2.02
Volume
481.1K
Avg Volume
866.6K
Performance
1M
+0.06%
3M
-17.89%
6M
+84.95%
YTD
-13.57%
1Y
+12.06%
3Y
+71.54%
5Y
-65.59%
Price Chart
ETF Exposure
NRIX is held by 106 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 2.50% |
| HEAL | Global X - HealthTech ETF | 1.16% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.63% |
| IWC | iShares Micro-Cap ETF | 0.33% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.32% |
| CURE.AX | Global X - S&P Biotech ETF | 0.31% |
| XBI | State Street SPDR S&P Biotech ETF | 0.31% |
| XWD1.F | Xtrackers MSCI World Swap UCITS ETF | 0.30% |
| XWD1.SG | Xtrackers MSCI World Swap UCITS ETF | 0.30% |
| XWEH.DE | Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged | 0.30% |
| IBB | iShares Biotechnology ETF | 0.14% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.12% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.12% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.11% |
| IWN | iShares Russell 2000 Value ETF | 0.11% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.10% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.09% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.09% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.07% |
| PWS | Pacer WealthShield ETF | 0.07% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.07% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.07% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.06% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.05% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.05% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% |
| VTWO | Vanguard Russell 2000 ETF | 0.05% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.05% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.05% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.05% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.05% |
| RSSL | Global X - Russell 2000 ETF | 0.05% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.05% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.04% |
| UWM | ProShares - Ultra Russell2000 | 0.04% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.03% |
| DRUP.DE | Amundi MSCI Disruptive Technology UCITS ETF Acc | 0.03% |
| DTEC.L | Amundi MSCI Disruptive Technology UCITS ETF Acc | 0.03% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.03% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.03% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.03% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.02% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.02% |
| VHT | Vanguard Health Care ETF | 0.02% |
Page 1 of 3Next
About NRIX ETF Exposure
Nurix Therapeutics, Inc. (NRIX) is held by 106 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.3B, NRIX is a widely held institutional stock. The stock currently trades at $15.03. Investors can gain exposure to NRIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NRIX, sorted by portfolio weight.